Does the clamping method in local and systemic TXA applications in total knee arthroplasty change the game?: A retrospective comparative cohort study
暂无分享,去创建一个
[1] M. Hantes,et al. Octogenarians Are the New Sexagenarians: Cruciate-Retaining Total Knee Arthroplasty Is Not Inferior to Posterior-Stabilized Arthroplasty in Octogenarian Patients , 2022, Journal of clinical medicine.
[2] Wei Huang,et al. Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty , 2022, Journal of Orthopaedic Surgery and Research.
[3] Wei Huang,et al. Efficacy of a three-day prolonged-course of multiple-dose versus a single-dose of tranexamic acid in total hip and knee arthroplasty , 2020, Annals of translational medicine.
[4] M. Grecula. CORR Insights®: Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial. , 2019, Clinical orthopaedics and related research.
[5] D. Tong,et al. Hidden blood loss after hip hemiarthroplasty using the superPATH approach: A retrospective study. , 2019, Injury.
[6] Bo Yang,et al. Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis , 2019, Medicine.
[7] Jiang Chen,et al. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials , 2019, BMJ Open.
[8] T. Rasmussen,et al. Fibrinolysis in trauma: a review , 2018, European Journal of Trauma and Emergency Surgery.
[9] David B Hoyt,et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.
[10] A. Rasi,et al. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. , 2014, The Journal of arthroplasty.
[11] M. Vasso,et al. Knee flexion after total knee arthroplasty reduces blood loss , 2014, Knee Surgery, Sports Traumatology, Arthroscopy.
[12] M. Pagnano,et al. Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty , 2013, Clinical orthopaedics and related research.
[13] Sumit Jain,et al. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.
[14] R. Maniar,et al. Most Effective Regimen of Tranexamic Acid in Knee Arthroplasty: A Prospective Randomized Controlled Study in 240 Patients , 2012, Clinical orthopaedics and related research.
[15] Jun-Wen Wang,et al. Does Tranexamic Acid Save Blood in Minimally Invasive Total Knee Arthroplasty? , 2011, Clinical orthopaedics and related research.
[16] T. Matsushita,et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty , 2011, International Orthopaedics.
[17] F. Chung,et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. , 2010, The Journal of bone and joint surgery. American volume.
[18] J. Eubanks. Antifibrinolytics in Major Orthopaedic Surgery , 2010, The Journal of the American Academy of Orthopaedic Surgeons.
[19] J. Douketis,et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. , 2009, Thrombosis research.
[20] J. Cid,et al. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta‐analysis of randomized controlled trials , 2005, Transfusion.
[21] P. Calder,et al. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. , 2003, The Knee.
[22] K. Ho,et al. Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysis , 2003, Anaesthesia and intensive care.
[23] L. Good,et al. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. , 2003, British journal of anaesthesia.
[24] F. Madsen,et al. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study , 2002, Acta anaesthesiologica Scandinavica.
[25] R. Abbate,et al. Effect of Tourniquet Use on Activation of Coagulation in Total Knee Replacement , 2000, Clinical orthopaedics and related research.
[26] C Longstaff,et al. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[27] Alan H. Todd. Arthroplasty , 1923, Definitions.
[28] P. Meshram,et al. Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial. , 2019, Clinical orthopaedics and related research.
[29] Walid Mohamed Emara,et al. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty , 2014, Anesthesia, essays and researches.
[30] C. Samama,et al. Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. , 2013, Thrombosis research.
[31] I. Nilsson. Clinical pharmacology of aminocaproic and tranexamic acids , 1980, Journal of clinical pathology. Supplement.
[32] Å. Ahlberg,et al. Diffusion of tranexamic acid to the joint. , 1976, Acta Orthopaedica Scandinavica.